Sato K, Miyakawa M, Onoda N, Demura H, Yamashita T, Miura M, Kasajima T, Yamazaki K, Obara T
Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Shinjuku-ku, Japan.
J Clin Endocrinol Metab. 1997 Jun;82(6):1968-73. doi: 10.1210/jcem.82.6.3989.
Human thyrocytes produce vascular endothelial growth factor (VEGF), a potent angiogenic factor, also known as vascular permeability factor (VPF), which increases vascular permeability. Based on the assumption that VEGF/VPF is involved in fluid accumulation in thyroid cysts, we determined the VEGF/VPF concentration in cyst fluids of thyroid nodules from 79 patients. VEGF/VPF was found to be abundantly present in the cyst fluids (0.02-183 ng/mL). There was no significant difference of VEGF/VPF concentration in the cyst fluid obtained from thyroid adenoma or from adenomotous goiter with cystic degeneration. Immunoreactive VEGF/VPF in cyst fluid was eluted mainly at 45 kDa, and stimulated endothelial cell proliferation, which was partially blocked by anti-VEGF/VPF antibody. The VEGF/ VPF concentration in the cyst fluid obtained from patients who required repeated aspiration or underwent surgical resection because of recurrent accumulation (84.8 +/- 58.3 ng/mL, mean +/- SD, n = 18) was significantly higher than that in the cysts that regressed or disappeared after a single aspiration (4.3 +/- 4.4 ng/mL, n = 12, P < 0.001). These in vitro and clinical findings suggest that VEGF/VPF is at least partly involved in the accumulation of cyst fluid in thyroid nodules, and that a high VEGF/VPF concentration predicts rapid accumulation of the cyst fluid, possibly necessitating interventional treatment.
人类甲状腺细胞可产生血管内皮生长因子(VEGF),这是一种强效血管生成因子,也被称为血管通透因子(VPF),它可增加血管通透性。基于VEGF/VPF参与甲状腺囊肿液体蓄积的假设,我们测定了79例患者甲状腺结节囊液中的VEGF/VPF浓度。结果发现囊液中大量存在VEGF/VPF(0.02 - 183 ng/mL)。从甲状腺腺瘤或囊性变的腺瘤样甲状腺肿获取的囊液中,VEGF/VPF浓度无显著差异。囊液中的免疫反应性VEGF/VPF主要在45 kDa处洗脱,并可刺激内皮细胞增殖,而抗VEGF/VPF抗体可部分阻断这一作用。因反复积液而需要反复抽吸或接受手术切除的患者(84.8 +/- 58.3 ng/mL,均值 +/- 标准差,n = 18)的囊液中VEGF/VPF浓度,显著高于单次抽吸后消退或消失的囊肿(4.3 +/- 4.4 ng/mL,n = 12,P < 0.001)。这些体外和临床研究结果表明,VEGF/VPF至少部分参与了甲状腺结节囊液的蓄积,且高VEGF/VPF浓度预示着囊液会快速蓄积,可能需要进行介入治疗。